316
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation

, , , , , , , , , , , , & show all
Article: 2349059 | Received 19 Dec 2023, Accepted 25 Apr 2024, Published online: 16 May 2024

References

  • Khattak MA, Martin HL, Beeke C, et al. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer. 2012;11(4):1–11. doi: 10.1016/j.clcc.2012.06.004.
  • Engstrand J, Nilsson H, Strömberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. doi: 10.1186/s12885-017-3925-x.
  • Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10–32. doi: 10.1016/j.annonc.2022.10.003.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-A 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of Colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175. doi: 10.1007/s00270-012-0377-1.
  • Han K, Kim JH, Yang SG, et al. A single-center retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases. Radiology. 2020;298(1):212–218. doi: 10.1148/RADIOL.2020200109.
  • Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28(7):2727–2734. doi: 10.1007/s00330-017-5273-2.
  • De Cobelli F, Calandri M, Della Corte A, et al. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study. Eur Radiol. 2022;32(6):4147–4159. doi: 10.1007/s00330-021-08497-2.
  • Mori M, Palumbo D, Muffatti F, et al. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. Eur Radiol. 2022;33(6):4412–4421. doi: 10.1007/s00330-022-09351-9.
  • Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi: 10.1148/radiol.2015151169.
  • Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi: 10.1016/j.ejca.2011.11.036.
  • Altazi BA, Fernandez DC, Zhang GG, et al. Investigating multi-radiomic models for enhancing prediction power of cervical cancer treatment outcomes. Phys Med. 2018;46:180–188. doi: 10.1016/j.ejmp.2017.10.009.
  • Palumbo D, Mori M, Prato F, et al. Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: a multidisciplinary, machine learning-based approach. Cancers. 2021;13(19):4938. doi: 10.3390/cancers13194938.
  • Panzeri MM, Losio C, Della Corte A, et al. Prediction of chemoresistance in women undergoing neo-adjuvant chemotherapy for locally advanced breast cancer: volumetric analysis of first-order textural features extracted from multiparametric MRI. Contrast Media Mol Imaging. 2018;2018:8329041–8329047. doi: 10.1155/2018/8329041.
  • Taghavi M, Staal F, Gomez Munoz F, et al. CT-based radiomics analysis before thermal ablation to predict local tumor progression for colorectal liver metastases. Cardiovasc Intervent Radiol. 2021;44(6):913–920. doi: 10.1007/s00270-020-02735-8.
  • Zech CJ, Korpraphong P, Huppertz A, et al. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014;101(6):613–621. doi: 10.1002/bjs.9465.
  • Kim C, Kim SY, Kim M-J, et al. Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer. Eur Radiol. 2018;28(10):4234–4242. doi: 10.1007/s00330-018-5422-2.
  • Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–321. doi: 10.1097/00000658-199909000-00004.
  • Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30(5):979–985. doi: 10.1118/1.1568978.
  • Apte AP, Iyer A, Crispin-Ortuzar M, et al. Technical note: Extension of CERR for computational radiomics: a comprehensive MATLAB platform for reproducible radiomics research. Med Phys. 2018;45(8):3713–3720. doi: 10.1002/mp.13046.
  • Whybra P, Parkinson C, Foley K, et al. Assessing radiomic feature robustness to interpolation in 18F-FDG PET imaging. Sci Rep. 2019;9(1):9649. doi: 10.1038/s41598-019-46030-0.
  • Piazzese C, Foley K, Whybra P, et al. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer. PLOS One. 2019;14(11):e0225550. doi: 10.1371/journal.pone.0225550.
  • Zwanenburg A, Vallières M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328–338. doi: 10.1148/radiol.2020191145.
  • Desseroit M-C, Tixier F, Weber WA, et al. Reliability of PET/CT shape and heterogeneity features in functional and morphologic components of non-small cell lung cancer tumors: a repeatability analysis in a prospective multicenter cohort. J Nucl Med. 2017;58(3):406–411. doi: 10.2967/jnumed.116.180919.
  • Loi S, Mori M, Benedetti G, et al. Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms. Phys Med. 2020;76:125–133. doi: 10.1016/j.ejmp.2020.06.025.
  • Mori M, Benedetti G, Partelli S, et al. Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. Phys Med. 2019;57:41–46. doi: 10.1016/j.ejmp.2018.12.005.
  • Belli ML, Mori M, Broggi S, et al. Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Phys Med. 2018;49:105–111. doi: 10.1016/j.ejmp.2018.05.013.
  • Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379. doi: 10.1016/S0895-4356(96)00236-3.
  • Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol. 2007;165(6):710–718. doi: 10.1093/aje/kwk052.
  • Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Newyork (NY): Springer Science + Business Media, LLC; 2009.
  • Collins GS, Moons KGM, Dhiman P, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;385(j 4):e078378–g7594. doi: 10.1136/bmj.g7594.
  • Shur J, Orton M, Connor A, et al. A clinical-radiomic model for improved prognostication of surgical candidates with colorectal liver metastases. J Surg Oncol. 2020;121(2):357–364. doi: 10.1002/jso.25783.
  • Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes-a 10-year experience at a single center. Radiology. 2016;278(2):601–611. doi: 10.1148/radiol.2015142489.
  • Zirakchian Zadeh M, Sotirchos VS, Kirov A, et al. Three-dimensional margin as a predictor of local tumor progression after microwave ablation: intraprocedural versus 4–8-week postablation assessment. J Vasc Interv Radiol. 2024;35(4):523–532.e1. doi: 10.1016/j.jvir.2024.01.001.
  • Chlorogiannis D-D, Sotirchos VS, Georgiades C, et al. The importance of optimal thermal ablation margins in colorectal liver metastases: a systematic review and meta-analysis of 21 studies. Cancers . 2023;15(24):5806. doi: 10.3390/cancers15245806.
  • Lin Y-M, Paolucci I, O’Connor CS, et al. Ablative margins of colorectal liver metastases using deformable CT image registration and autosegmentation. Radiology. 2023;307(2):e221373. doi: 10.1148/RADIOL.221373.
  • Vasiniotis Kamarinos N, Gonen M, Sotirchos V, et al. 3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases. Int J Hyperthermia. 2022;39(1):880–887. doi: 10.1080/02656736.2022.2055795.
  • Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18(2):299–304. doi: 10.1093/annonc/mdl386.
  • Bhayana R, Baliyan V, Kordbacheh H, et al. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns. Eur Radiol. 2021;31(3):1359–1366. doi: 10.1007/s00330-020-07228-3.
  • Park SH, Kim H, Kim EK, et al. Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI. Oncotarget. 2017;8(41):71012–71023. doi: 10.18632/oncotarget.20295.
  • Alonzo M, Bos A, Bennett S, et al. The EmprintTM ablation system with ThermosphereTM technology: one of the newer next-generation microwave ablation technologies. Semin Intervent Radiol. 2015;32(4):335–338. doi: 10.1055/s-0035-1564811.
  • Cornelis FH, Petre EN, Vakiani E, et al. Immediate postablation 18 F-FDG injection and corresponding SUV are surrogate biomarkers of local tumor progression after thermal ablation of colorectal carcinoma liver metastases. J Nucl Med. 2018;59(9):1360–1365. doi: 10.2967/jnumed.117.194506.
  • Shyn PB, Cubre AJ, Catalano PJ, et al. F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin. Abdom Radiol. 2021;46(7):3437–3447. doi: 10.1007/s00261-021-02970-8.
  • Zirakchian Zadeh M, Yeh R, Kunin HS, et al. Real-time split-dose PET/CT-guided ablation improves colorectal liver metastasis detection and ablation zone margin assessments without the need for repeated contrast injection. Cancers. 2022;14(24):6253. doi: 10.3390/cancers14246253.
  • Zirakchian Zadeh M, Yeh R, Kirov AS, et al. Gradient-based volumetric PET parameters on immediate pre-ablation FDG-PET predict local tumor progression in patients with colorectal liver metastasis treated by microwave ablation. Cardiovasc Intervent Radiol. 2023;46(7):911–920. doi: 10.1007/s00270-023-03470-6.